会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • SUBSTITUTED FUSED PYRAZOLECARBOXYLIC ACID ARYLAMIDES AND RELATED COMPOUNDS
    • 取代的共聚吡咯并苯甲酸和相关化合物
    • WO2003066634A1
    • 2003-08-14
    • PCT/US2003/003872
    • 2003-02-07
    • NEUROGEN CORPORATIONMAYNARD, GeorgeYUAN, JunRACHWAL, Stanislaw
    • MAYNARD, GeorgeYUAN, JunRACHWAL, Stanislaw
    • C07D471/04
    • C07D471/04C07B2200/05C07D487/04
    • Heterocyclic compounds such as 3,4,5,6-tetrahydro-2,3,10-triaza-benzo[e]azulene-1-carboxylic acid arylamides, 5,7-Dihydro-6H-pyrazolo[3,4-h]quinoline-9-carboxylic acid arylamides, 5,7-Dihydro-6H-pyrazolo[3,4-h]quinazoline-9-carboxylic acid arylamides, 2,4,5,6-Tetrahydro-1,2,6,7-tetraaza-as-indacene-8-carboxylic acid arylamides and related compounds are disclosed. These compounds are highly selective agonists, antagonists or inverse agonists for GABA A brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABA A brain receptors and are therefore useful in the treatment of anxiety, depression, sleep and seizure disorders, overdose with benzodiazepine drugs, Alzheimer's dementia, and for enhancement of memory. Pharmaceutical compositions, including packaged pharmaceutical compositions, are further provided. Intermediates useful for the synthesis of pyrazolecarboxylic acid arylamides are also provided. Compounds of the invention are also useful as probes for the localization of GABA A receptors in tissue samples.
    • 杂环化合物如3,4,5,6-四氢-2,3,10-三氮杂 - 苯并[e]薁-1-羧酸芳基酰胺,5,7-二氢-6H-吡唑并[3,4-h] 喹啉-9-羧酸芳基酰胺,5,7-二氢-6H-吡唑并[3,4-h]喹唑啉-9-羧酸芳基酰胺,2,4,5,6-四氢-1,2,6,7- 四氮杂 - 引嗪并] -8-羧酸芳基酰胺和相关化合物。 这些化合物是用于GABAA脑受体的G选择性激动剂,拮抗剂或反向激动剂或GABAA脑受体的激动剂,拮抗剂或反向激动剂的前药,因此可用于治疗焦虑,抑郁,睡眠和癫痫发作,用苯二氮卓类药物过量服用, 阿尔茨海默病的痴呆,并增强记忆力。 还提供药物组合物,包括包装的药物组合物。 还提供了可用于合成吡唑甲酰芳基酰胺的中间体。 本发明的化合物也可用作组织样品中GABA A受体定位的探针。
    • 6. 发明申请
    • 3-SUBSTITUTED 1,2,3-TRIAZIN-4-ONE'S AND 3-SUBSTITUTED 1,3-PYRIMIDINONE'S FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES
    • 3-取代的1,2,3-三嗪-4-酮和3-取代的1,3-嘧啶酮用于增强谷氨酰胺能突触反应
    • WO2009038752A2
    • 2009-03-26
    • PCT/US2008/010877
    • 2008-09-19
    • CORTEX PHARMACEUTICALS, INC.MUELLER, RudolfSTREET, Leslie, J.RACHWAL, StanislawALISALA, Kashinatham
    • MUELLER, RudolfSTREET, Leslie, J.RACHWAL, StanislawALISALA, Kashinatham
    • C07D255/04
    • C07D487/04
    • This invention relates to compounds, pharmaceutical compositions and methods for use in the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for basic and higher order behaviors. These brain networks, which are involved in regulation of breathing, and cognitive abilities related to memory impairment, such as is observed in a variety of dementias, in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia, respiratory depression, sleep apneas, attention deficit hyperactivity disorder and affective or mood disorders, and in disorders wherein a deficiency in neurotrophic factors is implicated, as well as in disorders of respiration such as overdose of an alcohol, an opiate, an opioid, a barbiturate, an anesthetic, or a nerve toxin, or where the respiratory depression results form a medical condition such as central sleep apnea, stroke- induced central sleep apnea, obstructive sleep apnea, congenital hypoventilation syndrome, obesity hypoventilation syndrome, sudden infant death syndrome, Rett syndrome, spinal cord injury, traumatic brain injury, Cheney-Stokes respiration, Ondines curse, Prader-Willi's syndrome and drowning. In a particular aspect, the invention relates to compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.
    • 本发明涉及用于预防和治疗脑功能不全的化合物,药物组合物和方法,包括增强负责基本和更高级行为的脑网络中的突触中的受体功能。 这些参与调节呼吸的脑网络以及与记忆障碍有关的认知能力,诸如在各种痴呆症中观察到的,在不同大脑区域之间的神经元活动的不平衡中,如帕金森病, 精神分裂症,呼吸抑制,睡眠呼吸暂停,注意力缺陷多动障碍和情感或情绪障碍,以及涉及神经营养因子缺乏的障碍,以及呼吸障碍如过量饮酒,阿片制剂,阿片类药物, 巴比妥类药物,麻醉剂或神经毒素,或者其中呼吸抑制导致形成诸如中枢性睡眠呼吸暂停,中风性睡眠呼吸暂停,阻塞性睡眠呼吸暂停,先天性换气不足综合征,肥胖性低通气综合征,婴儿猝死综合征 ,Rett综合征,脊髓损伤,创伤性脑损伤,Cheney-Stokes呼吸,Ondines诅咒 e,Prader-Willi综合症和溺水。 在一个特定方面,本发明涉及可用于治疗这些病症的化合物,以及使用这些化合物进行这种治疗的方法。